Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 1 of 1 for:    hepatocellular carcinoma sorafenib mFOLFOX
Previous Study | Return to List | Next Study

Sorafenib + mFOLFOX for Hepatocellular Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Massachusetts General Hospital
Sponsor:
Information provided by (Responsible Party):
Andrew X. Zhu, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01775501
First received: January 18, 2013
Last updated: January 31, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)